Tonix Pharmaceuticals Holding Corp.
Cash Flow
Last updated:
Cash flow statement presents a set of outflows and inflows of cash within a company through operating, investing and financing activities. Over the last year, operating activities of Tonix Pharmaceuticals Holding Corp. generated cash of -$102,003,000, which is less than the previous year. Cash used in financing activities reached the amount of $36,517,000 last year. Net change in cash is therefore -$94,621,000.
Cash Flow
| 2014 | -22.84M | -392K | 53.21M |
|---|---|---|---|
| 2015 | -42.52M | -24.17M | 47.69M |
| 2016 | -37.31M | 16.59M | 20.49M |
| 2017 | -19.12M | 7.16M | 18.51M |
| 2018 | -23.97M | -6K | 23.53M |
| 2019 | -26.68M | -17K | 12.91M |
| 2020 | -48.56M | -8.56M | 123.10M |
| 2021 | -75.55M | -35.30M | 212.48M |
| 2022 | -98.05M | -48.14M | 87.84M |
| 2023 | -102.00M | -29.07M | 36.51M |
TNXP Cash Flow Statement (2014 – 2023)
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | |
|---|---|---|---|---|---|---|---|---|---|---|
Cash at beginning of period | 120.47M | 178.9M | 77.30M | 11.34M | 25.13M | 25.58M | 19.03M | 19.17M | 38.18M | 8.20M |
Operating activities | ||||||||||
Net income | -116.65M | -110.21M | -92.28M | -50.46M | -28.61M | -26.08M | -21.12M | -38.84M | -48.05M | -27.61M |
| Adjustments to reconcile net income to cash generated by operating activities: | ||||||||||
Depreciation and amortization | 4.29M | 1.25M | 50K | 27K | 26K | 54K | 70K | 206K | 161K | 36K |
Stock-based compensation expense | 9.27M | 10.91M | 7.89M | 2.87M | 1.45M | 0 | 1.79M | 3.26M | 4.38M | 3.08M |
| Deferred income tax benefit | 9.27M | 10.91M | 7.89M | 2.87M | 1.45M | 0 | 1.79M | 3.26M | 4.38M | 3.08M |
| Changes in operating assets and liabilities: | ||||||||||
Accounts receivable, net | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Inventories | 61K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Accounts payable | -3.49M | -1.04M | 3.52M | 1.52M | 1.66M | 106K | 424K | -2.18M | 1.58M | 728K |
Cash generated by operating activities | -102.00M | -98.05M | -75.55M | -48.56M | -26.68M | -23.97M | -19.12M | -37.31M | -42.52M | -22.84M |
Investing activities | ||||||||||
Purchases Of Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -28.64M | 0 |
Investments In Property Plant And Equipment | -7.89M | -48.14M | -35.30M | -8.56M | -17K | -6K | -5K | -66K | -238K | -319K |
Acquisitions Net | -22.17M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 120K | 0 |
Cash generated by investing activities | -29.07M | -48.14M | -35.30M | -8.56M | -17K | -6K | 7.16M | 16.59M | -24.17M | -392K |
Financing activities | ||||||||||
Common Stock Issued | 18.93M | 135.09M | 212.48M | 123.10M | 5.83M | 12.71M | 18.50M | 20.49M | 47.68M | 0 |
Payments for dividends | 0 | -6.65M | 0 | 0 | -2.47M | 0 | 0 | 0 | 0 | 0 |
Repurchases of common stock | -13.96M | -47.25M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Repayments of term debt | 8.94M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Cash used in financing activities | 36.51M | 87.84M | 212.48M | 123.10M | 12.91M | 23.53M | 18.51M | 20.49M | 47.69M | 53.21M |
Net Change In Cash | -94.62M | -58.43M | 101.59M | 65.95M | -13.78M | -451K | 6.55M | -234K | -19.00M | 29.98M |
Cash at end of period | 25.84M | 120.47M | 178.9M | 77.30M | 11.34M | 25.13M | 25.58M | 18.94M | 19.17M | 38.18M |
| Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source |